Depressive Symptoms Clinical Trial
Official title:
ICBT for Depression - A Factorial Investigation of Kinds of Therapist Support and Self-/Expert-selected Content
NCT number | NCT04260750 |
Other study ID # | LUNA |
Secondary ID | |
Status | Completed |
Phase | N/A |
First received | |
Last updated | |
Start date | January 13, 2020 |
Est. completion date | April 15, 2021 |
Verified date | April 2021 |
Source | Linkoeping University |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
The study is a factorial randomized controlled trial investigating the efficacy of difference versions of internet-administered cognitive behavioral therapy.
Status | Completed |
Enrollment | 246 |
Est. completion date | April 15, 2021 |
Est. primary completion date | April 15, 2021 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years and older |
Eligibility | Inclusion Criteria: - Current depressive symptoms equivalent to a score of at least 5 on Patient Health Questionnaire 9 and a minimum of 10 points on Becks Depression Inventory. - 18 years or older. - Adequate ability to understand and speak Swedish. - Access to the internet and a smartphone/computer. Exclusion Criteria: - Other ongoing psychological treatment or counselling. - Recent (within the past 3 months) changes in the dose of psychotropic medication. - Prior diagnosis of psychosis, bipolar disorder, or substance dependence. |
Country | Name | City | State |
---|---|---|---|
Sweden | Linköping University | Linköping | Östergötland |
Lead Sponsor | Collaborator |
---|---|
Linkoeping University |
Sweden,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Change on Becks Depression Inventory-II (BDI-II) | Measure of depressive symptoms. Possible range for the total sum: 0 to 63 (created by summing up the score from each item). Clinical ranges for minimal, mild, moderate and severe major depressive disorder are considered to be 0-13, 13-19, 20-28, and 29-63 points. | Baseline, after the intervention (after 11 weeks), 12 months after the end of intervention. | |
Primary | Change on Patient Health Questionnaire (PHQ-9) | Measure of depressive symptoms. Possible range for the total sum: 0 to 27 (created by summing up the score from each item). Clinical cut-offs for mild, moderate, moderately severe and severe major depressive disorder are considered to be 5, 10, 15, and 20 points. | Baseline, during week 1, 2, 3, 4, 5, 6, 7, 8, 9, and 10 of the intervention, post-intervention (after 11 weeks), 12 months after the end of intervention. | |
Secondary | Change on Generalised Anxiety Disorder 7-item scale (GAD-7) | Measure of symptoms of generalised anxiety disorder (GAD). Seven items, the score is interpreted by summing up the score from each individual item. Higher scores indicate more severe problems with worry and generalised anxiety. The total sum ranges from 0 to 21 with cut-offs of 5, 10, and 15 representing mild, moderate and severe generalised anxiety. | Baseline, after the intervention (after 11 weeks), 12 months after the end of intervention. | |
Secondary | Change on Brunnsviken Brief Quality of Life Scale (BBQ) | Measure of quality of life, total score ranging from 0 to 96 with a higher score indicating a higher quality of life. The scores of each of the six primary questions regarding perceived quality of life within an area of life are multiplied with the score of an item measuring the perceived importance of the area in question. | Baseline, after the intervention (after 11 weeks), 12 months after the end of intervention. | |
Secondary | Change on Insomnia Severity Index (ISI) | Measure of insomnia severity and symptoms of disordered sleep. The total score can range between 0 (no sleep problems) to 28 (severe sleep problems and insomnia). Norm score ranges include low likelihood of sleep problems (0 to 7 points), some sleep problems (8 to 14 points), moderate sleep problems (15 to 21 points), severe sleep problems (22 to 28 points). | Baseline, after the intervention (after 11 weeks), 12 months after the end of intervention. |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT02909387 -
Adapting Project UPLIFT for Blacks in Georgia
|
N/A | |
Completed |
NCT05702086 -
Making SPARX Fly in Nunavut: Pilot Testing an E-intervention for Boosting Resilience Against Youth Depression
|
N/A | |
Terminated |
NCT04921332 -
Bright Light Therapy for Depression Symptoms in Adults With Cystic Fibrosis (CF) and COPD
|
N/A | |
Completed |
NCT03535805 -
Transdiagnostic, Cognitive and Behavioral Intervention for in School-aged Children With Emotional and Behavioral Disturbances
|
N/A | |
Recruiting |
NCT06100146 -
Effectiveness of Fortification With Folic Acid and Vitamin B12 Among Teenage Girls
|
N/A | |
Recruiting |
NCT03272230 -
Assessment of Apathy in a Real-life Situation, With a Video and Sensors-based System
|
N/A | |
Completed |
NCT03514355 -
MBSR in Rheumatoid Arthritis Patients With Controlled Disease But Persistent Depressive Symptoms
|
N/A | |
Completed |
NCT05376397 -
Testing THRIVE 365 for Black Sexual Minority Men (On The Daily)
|
N/A | |
Terminated |
NCT04367636 -
The Effects of Attention Training on Emotion Regulation and Stress Related Complaints During COVID-19
|
N/A | |
Completed |
NCT04403126 -
To Increase Psychological Well-being by the Implementation of Forgiveness Education
|
N/A | |
Recruiting |
NCT05078424 -
Cognitive Behavioural Therapy for Youths With Depressive and Anxiety Symptoms in Hong Kong
|
N/A | |
Recruiting |
NCT06053775 -
Non-Invasive Brain Stimulation and Cognitive Training for Depressive Symptomatology Related to Breast Cancer (ONCODEP)
|
N/A | |
Active, not recruiting |
NCT04084795 -
Augmentation of EMDR With tDCS in the Treatment of Fibromyalgia
|
N/A | |
Recruiting |
NCT04082052 -
Evaluating and Predicting Response to a Single Session Intervention for Self-Dislike
|
N/A | |
Completed |
NCT04011540 -
Digital Data in Mental Health Therapy
|
N/A | |
Not yet recruiting |
NCT06413849 -
Telephone-coached "Graphic Narrative" Bibliotherapy for Dementia Caregivers
|
N/A | |
Not yet recruiting |
NCT03659591 -
Triple Aim Psychotherapy: Aimed at Improving Patient Experience, Population Health, and Cost
|
N/A | |
Not yet recruiting |
NCT02133170 -
"Mindfulness vs Psychoeducation in Bipolar Disorder"
|
N/A | |
Completed |
NCT02314390 -
Group- Versus Individual-Mindfulness-Based Cognitive Therapy: a Randomized Trial
|
N/A | |
Completed |
NCT01628016 -
The Effect of Attention Bias Modification Training on Reducing Depressive Symptoms
|
N/A |